dedup-isc-ft-v107-score
float64 0.3
1
| uid
stringlengths 32
32
| text
stringlengths 1
17.9k
| paper_id
stringlengths 8
11
| original_image_filename
stringlengths 7
69
|
|---|---|---|---|---|
0.387708 | de46418bc2d147e5b1e1efcb9592ceae | Evolution of the open circuit potential for the samples evaluated. | PMC9735538 | materials-15-08328-g015.jpg |
0.43099 | bc52977027ff46adb40a120bcda692ac | (a). Polarization curve for (Acqua 100) with corresponding settings. (b). Polarization curve for (Acqua 100 + 0.5% NPs) with corresponding settings. (c). Polarization curve for (Acqua 100 + 1% NPs) with corresponding settings. | PMC9735538 | materials-15-08328-g016.jpg |
0.429433 | 64386d4225484fadb1308510f470c917 | Robotic free pericardial fat pledget technique for treating pulmonary air leak. | PMC9737043 | fx1.jpg |
0.455229 | d5e86a7afdda4a958c0dc6a5723ed56e | Sealing test. Two points of air leak due to interlobar fissure division (arrows). RUL, Right upper lobe; RML, right middle lobe. | PMC9737043 | gr1.jpg |
0.426656 | 5346d64bbd924bf1b9d72c63a15e77cf | Details of the FPFP technique. A, Harvesting pericardial fat using Maryland bipolar forceps. The dashed line shows the line where the pericardial fat is divided. B, Sandwiching the air leak point with 2 FPFPs. C, Horizontal mattress suturing. The dashed line shows PDS in the lung parenchyma. D, Intraluminal ligation. E, Completion of the FPFP technique. F, Main schema of the FPFP technique. RUL, Right upper lobe; RML, right middle lobe; FPFP, free pericardial fat pledget. | PMC9737043 | gr2.jpg |
0.470117 | 052af025caa44c95b1a43f8c8fc38a78 | Theoretical architecture. | PMC9737687 | ijerph-19-16032-g001.jpg |
0.420541 | 0262ae4f67214faf86f525653aefc5eb | (a) Cartoon representation of cytochrome c, with the heme group and the protein backbone colored green and blue, respectively. (b) Tetrasulfonato-calix[4]arene sclx4 that yielded the first cocrystal with this protein [18]. (c) Tetra-alanino-calix[4]arene-biscrown-3 1 studied in this work. | PMC9737847 | ijms-23-15391-g001.jpg |
0.484794 | 580bd56233bf48a38bdb03d2ab1c7433 | (a) Overlaid 1H–15N HSQC spectral region of 0.1 mM cytochrome c in the absence (black contours) or in the presence of 0.1–3.1 mM 1 (blue scale). (b) Chemical shift perturbation plots of cytochrome c amides at ∽30 eq. compound 1. Cytochrome c residues are numbered from –5 to 103. Blanks correspond to proline residues 25, 30, 71, and 76, and unassigned G84. | PMC9737847 | ijms-23-15391-g002.jpg |
0.453888 | c5bf99a0cdfd4085b6c9ae94d7122b83 | Binding map for compound 1 on cytochrome c. K4, K87, and K89 are colored green, and other residues with a significant chemical shift perturbation (Δδ 1HN≥ 0.04 or 15NH ≥ 0.4 ppm) are blue. The heme and prolines are black and grey, respectively. | PMC9737847 | ijms-23-15391-g003.jpg |
0.428805 | 5e20952feb3f4a8e96a8bbedd4cb3d09 | Experimental points and calculated binding curves for the two binding sites including (a) the group of residues around K4, and (b) K87 and K89. The experimental Δδ were fitted as a function of the concentration of 1 to a 1:1 binding model. | PMC9737847 | ijms-23-15391-g004.jpg |
0.442697 | 074817f5bc5e477aa050b9b9d3ef50cb | Overall workflow diagram for discovering and verifying the roles and mechanisms of ApoA-I-related ASD. | PMC9737945 | ijms-23-15290-g001.jpg |
0.491583 | 4a8e338d449d4c78a02e0ce19f9f6b26 | Identification of differential proteins (a–c) and GO/KOG functional classification (d,e). (a) The number of differentially expressed proteins was identified. Among them, 78 proteins were up-regulated and 46 proteins were down-regulated. (b) Volcanic map of differentially expressed proteins. Red represents upregulated proteins and green represents downregulated proteins. (c) Heatmap of differentially expressed proteins. Each small square represents a protein and the color indicates the level of expression. Red represents up-regulation and green represents down-regulation. The darker the color, the greater the expression. (d) GO functional classification of differentially expressed proteins. The abscissa represents the number of proteins and the ordinate represents the GO term name. (e) KOG functional classification of differentially expressed proteins. The abscissa indicates the number of proteins and the ordinate indicates the functional names in the different COG/KOG categories. | PMC9737945 | ijms-23-15290-g002.jpg |
0.402373 | b80d9538f02148418270f0364f65931e | Functional enrichment analysis of differential proteins. The abscissa indicates log2 fold enrichment and the ordinate indicates different GO terms or KEGG pathways. The redder the circle, the smaller the p-value, and the larger the circle, the more proteins that are represented. (a) GO biological process enrichment analysis. (b) GO cellular component enrichment analysis. (c) GO molecular function enrichment analysis. (d) KEGG pathway enrichment analysis. | PMC9737945 | ijms-23-15290-g003.jpg |
0.425461 | b9b867f0496f494b96a1b56e6424dbb4 | Protein–protein interaction network and screening of hub proteins. (a) Protein–protein interaction network of the top 50 differential proteins. (b) Protein–protein interaction network of the five screened hub proteins. The redder the color, the more protein connections there are in the network. | PMC9737945 | ijms-23-15290-g004.jpg |
0.412975 | e692ed23895342b9896f585b4b53a2f3 | Examination of ApoA-I and its downstream molecule SphK-S1P expression and ASD behavioral phenotypes in BTBR mice before and after SKI II intervention. (a,b) Representative Western blotting bands and quantification of the ApoA-I/β-tubulin, SphK1/β-tubulin, SphK2/β-tubulin ratios in the ApoA-I pathway. (c) RT-qPCR quantification mRNA expression of SphK1 and SphK2. (d,e) S1P levels in the serum and hippocampus before and after SKI II intervention. (f) Time spent self-grooming before and after SKI II intervention. (g,h) Representative roadmap and quantification of distance moved and movement duration before and after SKI II intervention in the open field test. N = 8–12 per group. All data are shown in bar diagrams, which reflect the arithmetic mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. | PMC9737945 | ijms-23-15290-g005.jpg |
0.418103 | 248c3aea0bfa403a858422236bd3d701 | Blockade of ApoA-I-related pathways improved social ability, spatial learning and memory function in BTBR mice. (a,b) Representative roadmap and quantification of social preference in the three-chamber test. (c,d) Representative roadmap and quantification of social novelty in the three-chamber test. (e,f) Representative roadmap and number of target quadrant crossings (passing times) of the Morris water maze test. N = 12 per group. All data are shown in bar diagrams, which reflect the arithmetic mean ± standard error of the mean. * p < 0.05, **** p < 0.0001. | PMC9737945 | ijms-23-15290-g006.jpg |
0.427547 | 2bd2be7492b94a038626a12403230b3e | ApoA-I-related pathway regulates the expression of proteins related to anxiety, cognition and spatial learning function, as well as the MAPK pathway in the hippocampus of the mice. (a,b) Representative Western blotting bands and quantification of the anxiety-related protein GAD1/β-actin ratios. (a,c) Representative Western blotting bands and quantification of the cognition- and spatial learning-related proteins (P-CaMKII)/CaMKII, (P-CREB)/CREB ratios. (d,e) Representative Western blotting bands and quantification of the MAPK pathway protein P-P38/P38, P-ERK/ERK ratios. N = 8 per group. All data are shown in bar diagrams, which reflect the arithmetic mean ± standard error of the mean. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. | PMC9737945 | ijms-23-15290-g007.jpg |
0.511206 | d0ff145ca37647d0b6e616fecb541719 | ApoA-I-related pathway regulates the expressions of proteins related to the apoptosis process and the KCNQ2 channel in the hippocampus of the mice. (a,b) Representative Western blotting bands and quantification of the apoptosis proteins, CDK5/β-tubulin, caspase-3/β-tubulin, Bax/β-tubulin and Bcl-2/GAPDH ratios. (c) Quantification of mRNA expression of KCND2, KCND3 and KCNJ10 channels. (d) Quantification of KCNQ2, and KCNQ3 mRNA expression. (e,f) Representative Western blotting bands and quantification of the M channel proteins, KCNQ2/GAPDH, and KCNQ3/GAPDH ratios. N = 8–10 per group. All data are shown in bar diagrams, which reflect the arithmetic mean ± standard error of the mean. * p < 0.05, ** p < 0.01. | PMC9737945 | ijms-23-15290-g008.jpg |
0.461794 | 2b7d4ffdcc064800ad42007f894389e1 | A flowchart depicting the preparation of ZnO-NPs utilizing an aqueous extract from Phoenix dactylifera L. and the processing of the different neat films and films reinforced with ZnO-NPs (1.0% w/w) (CA-based, CH-based, and GE-based film ZnO-NPs). | PMC9738154 | polymers-14-05202-g001.jpg |
0.446886 | 0b878d137df44230b4aac97def1590f1 | XRD spectra (standard ZnO diffraction pattern; JCPDS n°.01-079-2205) of ZnO-NPs synthesized utilizing an aqueous extract from Phoenix dactylifera L. | PMC9738154 | polymers-14-05202-g002.jpg |
0.517411 | 5423ddde9dd848c5ae9939fdf549b4ee | Transmission electron microscopy (TEM) of the ZnO-NPs synthesized utilizing an aqueous extract from Phoenix dactylifera L. | PMC9738154 | polymers-14-05202-g003.jpg |
0.427563 | 33bd1feeff1f4b51a7fac891aac35f8c | Water contact angle photographs of the different films reinforced with ZnO-NPs (1.0% w/w) (CA-based, CH-based, and GE-based film ZnO-NPs). Neat films without ZnO-NPs (CA-based, CH-based, and GE-based neat films) were added as reference. | PMC9738154 | polymers-14-05202-g004.jpg |
0.513542 | cd0d54ee67224b0dbb080db5bb8fb216 | Tensile test profiles of the different films reinforced with ZnO-NPs (1.0% w/w). (a). CA-based, (b). CH-based, and (c). GE-based film ZnO-NPs. Neat films without ZnO-NPs (CA-based, CH-based, and GE-based neat films) were added as reference. | PMC9738154 | polymers-14-05202-g005.jpg |
0.450513 | 0f3f75c223ae4164bd5d3c0c3c8e509b | Scanning electron microscopy (SEM) images for the thickness and surfaces of the different films reinforced with ZnO-NPs (1.0% w/w) (CA-based, CH-based, and GE-based film ZnO-NPs). Neat films without ZnO-NPs (CA-based, CH-based, and GE-based neat films) were added as reference. | PMC9738154 | polymers-14-05202-g006.jpg |
0.371209 | d156a50d5d5940a793974225116fbde2 | The layout of experiments on (a) multi-pulse sample drilling; (b) measurement of radiation distribution behind the drilled channel; (c) measurements of transmitted energy and distribution at the channel outlet. | PMC9738459 | materials-15-08347-g001.jpg |
0.408034 | 174271722af3445b8c0e2f08b4a1bf31 | (a) Beam profiler image of the focal spot obtained with UV converter and (b) normalized distributions of intensity (red curve) and energy fraction (blue curve) in the focal spot. | PMC9738459 | materials-15-08347-g002.jpg |
0.442911 | e0d9418cc11e42e68ed6fb80d8f8dfc9 | (a) Transmission spectra of (1) colorless PMMA of 1 mm thickness, (2) green PMMA of 3 mm and (3) yellow PMMA of 4 mm; (b) absorption coefficients in (1) colorless and (2) green PMMA. A dashed line designates the KrF laser wavelength. | PMC9738459 | materials-15-08347-g003.jpg |
0.439125 | e0b2e1f1fdbb44249ab04b026af570f0 | Video frame sequence of the growing channel in PMMA for the pulse energy (a–g) EL ≈ 2.8 and (h–n) 7 mJ. The laser beam falls on the sample from the right. | PMC9738459 | materials-15-08347-g004.jpg |
0.437212 | 111ff7e16e884c0f96b4af2b728c158d | Microscopic images of final channels produced in PMMA by a 10 Hz train of pulses with (a) EL = 0.3 mJ and (b) 22.3 mJ (a fragment of the channel end is shown). The laser beam falls on the sample from the right. | PMC9738459 | materials-15-08347-g005.jpg |
0.50048 | dc7e1a25cf3c44e18a8dd6574d5360ee | Channel length z vs. drilling time t for various pulse energies at a 10 Hz rep rate. | PMC9738459 | materials-15-08347-g006.jpg |
0.434573 | 575269c3398b4a5c916ef629583fb58d | Channel length Llin in dependence on incident pulse energy. | PMC9738459 | materials-15-08347-g007.jpg |
0.437151 | 83ab635e9bfe4a4e8846245f41a4f8cf | Channel length z vs. drilling time t for colorless and dyed PMMA samples at 10 Hz rep rate before saturation. | PMC9738459 | materials-15-08347-g008.jpg |
0.418644 | 4b80e85009c64a9e8da8e36476c4c957 | Microscopic images of channels drilled into K8 glass (a) by a train of pulses with EL = 2–4 mJ at a rep rate of 10 Hz for ~300 s, and (b) with EL ≈ 10 mJ at 40 Hz for ~ 180 s (not completed). The laser beam falls on the sample from the right. | PMC9738459 | materials-15-08347-g009.jpg |
0.388557 | 3bd0699790704fe4885b956e074b6d16 | A video frame of the optical breakdown in transparent KU-1 glass at a pulse energy EL ≈ 2 mJ. The laser beam falls on the sample from the right. | PMC9738459 | materials-15-08347-g010.jpg |
0.421506 | 9a7102e90ca547b785207294364db2f0 | Microscopic images of the breakdown damage and completed channels produced in KU-1 glass by a rep-rate irradiation at 10 Hz with pulse energies (a) EL ≈ 2.1; (b) EL ≈ 5.1; (c) EL ≈ 22 mJ. The laser beam falls on the sample from the right. | PMC9738459 | materials-15-08347-g011.jpg |
0.422556 | 8e43c5696c3d4e67939b84b6266ff578 | Channel transmittance and its dependence on PMMA thickness. The dots are measurements with calorimeters; the solid line is an exponential approximation with ζ = 0.4 and β = 0.085 mm−1. | PMC9738459 | materials-15-08347-g012.jpg |
0.478371 | 25d3ba7fd0ea428eb2342f885a4c2834 | Profiler images of the fluorescence of UV-to-green converter placed at a distance of 100 mm (a) behind the lens focus and outlets of the through-channels of various lengths (b) 4.8, (c) 6.5 and (d) 23 mm. Pulse energy is ~15 mJ. | PMC9738459 | materials-15-08347-g013.jpg |
0.499535 | 0f9e426321c849e6aa2326d3d960561b | Distribution of laser radiation at the outlet of the channel of 23 mm length at different pulse energies (a) 110 and (b) 11 mJ. | PMC9738459 | materials-15-08347-g014.jpg |
0.44154 | 08ed286adc1d45bfa76fe4bba429f71c | DIO reduced insulin resistance and improved dyslipidemia in D-NAFLD rats. (A) The structure of DIO. (B) Experimental design. (C) Insulin resistance index. (D) Serum triglyceride (mmol/L). (E) Serum total cholesterol (mmol/L). (F) Serum free fatty acids (mmol/L). (G) Serum LDL (mmol/L). (H) Serum HDL (mmol/L). n = 8 and the data were presented as mean ± SD. ns indicates no significance, * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g001.jpg |
0.443333 | 1671cdfebd714d6cb9c56089787fb149 | DIO relieved pancreatic injury and mitochondrial apoptosis in D-NAFLD rats. (A) H&E staining of pancreas, ×200. (B) Western blot images of Bax, Bcl2, CytC, Apaf-1, caspase 9, and caspase 3 in pancreas. (C) Relative protein expressions of Bax, Bcl2, CytC, Apaf-1, caspase 9, cleaved caspase 9, caspase 3, and cleaved caspase 3 in pancreas. n = 3 and the data were presented as mean ± SD. ns indicates no significance, * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g002.jpg |
0.518483 | 41cd4aed0c1a40df960df76be26f8d33 | DIO ameliorated liver damage and lipid deposition in D-NAFLD rats. (A) Liver/body weight. (B) Serum AST(U/L). (C) Serum ALT(U/L). (D) Liver triglyceride(mmol/g). (E) H&E staining of the liver (×20 and ×100) (black arrow, lipid vacuolation). Data in (A–D) (n = 8) and data in (E) (n = 3) were presented as mean ± SD. * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g003.jpg |
0.519726 | 2f323efaa09248758e0f3e79a27c2fdd | DIO inhibited hepatic steatosis through the regulation of AMPK-ACC/SREBP1 pathway. (A) The mRNA expressions of SREBP1c, FASN, CD36, PPARα, and CPT1. (B) Western blot images of SREBP1, ACC, p-ACC, and ACTB. (C) Relative protein expressions of SREBP1, ACC, and p-ACC. (D) Western blot images of p-AMPK, AMPK, and ACTB. (E) Relative protein expressions of AMPK and p-AMPK. (F) The images of AMPK immunohistochemistry, ×100, scale bars = 40 µm. Data in (A) (n = 5) and data in (B–F) (n = 3) were presented as mean ± SD. ns indicates no significance, * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g004.jpg |
0.501161 | a943c25db77a475c9a4f11d51da88c1e | DIO ameliorated ER stress and associated apoptosis in the liver of D-NAFLD rats. (A) Western blot images of PERK, p-PERK, IRE1, p-IRE1, XBP1s, and ACTB. (B) Western blot images of p-EIF2α, ATF4, CHOP, p-CHOP, and ACTB. (C) The images of p-PERK, IRE1, and caspase 12 immunohistochemistry, ×100, scale bars = 40 µm. | PMC9738614 | nutrients-14-04994-g005.jpg |
0.530484 | 20266731d2be4bc7858b7a9a9a77f99c | DIO ameliorated oxidative stress and inflammation in the liver of D-NAFLD rats. (A) DHE fluorescence, ×200, scale bars = 50 µm. (B) SOD level. (C) CAT level. (D) GPx level. (E) MDA level. (F) The mRNA expressions of MCP-1, IL-1β, TNF-α, IL-4 and IL-10. Data in (A) (n = 3) and data in (B–F) (n = 5) were presented as mean ± SD. ns indicates no significance, * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g006.jpg |
0.41128 | 8ca8e2f2bfa5439292a4939670d7c743 | DIO ameliorated mitochondrial apoptosis in the liver of D-NAFLD rats. (A) Western blot images of Bax, Bcl2, CytC, Apaf-1, caspase 9, cleaved caspase 9, caspase 3, cleaved caspase 3, and ACTB. (B) The images of CytC immunohistochemistry, ×100, scale bars = 40 µm. (C) Relative protein expressions of Bax, Bcl2, CytC, Apaf-1, caspase 9, cleaved caspase 9, caspase 3, and cleaved caspase 3. (D) CytC positive area in immunohistochemistry. n = 3 and the data were presented as mean ± SD. ns indicates no significance, * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g007.jpg |
0.446356 | 6053663459c649c280beef0867f7ae49 | DIO ameliorated the disorder of mitochondrial fission and fusion in the liver of D-NAFLD rats. (A) Western blot images of DRP1, p-DRP1, MFN1, MFN2, FIS1, ACTB, and GAPDH. (B) The images of MFN1 immunohistochemistry, ×100, scale bars = 40 µm. (C) The images of MFN2 and DRP1 immunohistochemistry, ×100, scale bars = 40 µm. (D) Relative protein expressions of DRP1, p-DRP1, FIS1, MFN1, and MFN2. (E) Positive staining area of MFN1, MFN2, and DRP1 immunohistochemistry. n = 3 and the data were presented as mean ± SD. ns indicates no significance, * and ** indicate significant difference and highly significant difference, respectively. | PMC9738614 | nutrients-14-04994-g008.jpg |
0.422696 | 0e76c776a06242619894f1da22ed61d5 | Structure information of the fourteen compounds analyzed in the GYJ samples. | PMC9738704 | molecules-27-08611-g001.jpg |
0.501818 | 10b126db7780452883ece4794903dee5 | Representative chromatogram. (A) Total Ions Chromatograph (TIC) of the mixed standards compared with the GYJ samples. (B) Chromatograms of individual extracts of each compound in GYJ samples. | PMC9738704 | molecules-27-08611-g002.jpg |
0.43302 | 81839ca99133490a8ec27b1bbfbed7c3 | Results of cluster analysis and multivariate statistical analysis for the content determination of 14 analytes of fifteen batches (S1–S15) of GYJ samples. (A) Heat map of cluster analysis; (B) Results of PCA analysis; (C) Results of OPLS-DA analysis; (D) VIP Score Graph. | PMC9738704 | molecules-27-08611-g003.jpg |
0.440483 | a705a617b97d41a58788f16fc46a577d | FSH signaling. In response to FSH binding to its specific receptor (FSHR), the corresponding G protein and β-arrestin subunits are activated. Gαs protein-associated signaling stimulates membrane adenylate cyclase (AC) to synthesize cAMP from ATP. PDE opposes the effects of adenylate cyclase by hydrolyzing cAMP. Elevated cAMP activates protein kinase A (PKA), thereby inducing pro-apoptotic signals and cytoskeleton changes (effects related to p38, MAPK, and JNK). cAMP/PKA/CREB activates steroidogenic signals. Epac, as an intracellular cAMP receptor, activates processes related to mitogenic signals (via mTOR) or survival signals (via AKT, the activity of which is also regulated by PI3K). FSH also activates the phospholipase C (PLC) and protein kinase C (PLC/PKC) pathways, which act on ERK1/ERK1/2 may also stimulate CREB. | PMC9738761 | cells-11-03835-g001.jpg |
0.44371 | 2467e4b65819456aba8ceb6bf599c45e | LH signaling. The binding of LH to a specific receptor (LHR) evokes its effects through G proteins (Gs and Gq/11) and β-arrestin. Activated adenylate cyclase (AC) increases the intracellular concentration of cAMP. PDE opposes the effects of adenylate cyclase by hydrolyzing cAMP. cAMP/PKA/CREB activates steroidogenic signals and proliferation. Gq/11 protein induces PLC/IP3/MAPK and/or PLC/PKC pathways stimulating cellular proliferation and differentiation. β-arrestin stimulates ERK1/2, and its action regulates proliferation and inhibits apoptosis. | PMC9738761 | cells-11-03835-g002.jpg |
0.439035 | e033619150b84d77b15ca2ca3ce907b9 | cAMP-dependent pathway in the ovarian cancer cell. Healthy ovarian cell exposed to the risk factors (red boxes) transforms phenotypically into neoplastic cell. Signaling cascades and maintenance of metabolism in the transformed cells may favor all features associated with growth, multiplication, metastasis, and survival. Activation of a cAMP-dependent pathway in the ovary occurs as a result of ligands (e.g., FSH and LH) binding to the G protein-coupled receptor. Changing the conformation of the receptor stimulates adenylate cyclase (AC) and increases cAMP concentration. | PMC9738761 | cells-11-03835-g003.jpg |
0.485738 | bc189894f3ac4d1cb4cba0b9f4c4747d | The boxplots presenting differences in flavonol intake between central obese participants and healthy control. | PMC9739955 | nutrients-14-05051-g001.jpg |
0.454655 | df91c90e43a74c5c9e4df337a7c45cd9 | Cure curves of TiO2-filled NBR composites with various TiO2 loadings. | PMC9739959 | polymers-14-05267-g001.jpg |
0.436734 | c23bcba31cba4120b9e2daabafcf1df5 | Mooney viscosity and hardness of TiO2-filled NBR composites with various TiO2 loadings. | PMC9739959 | polymers-14-05267-g002.jpg |
0.559881 | f1cd68ef121f4115a0ae467159a5c840 | Stress–strain behavior of TiO2-filled NBR composites with various TiO2 loadings. | PMC9739959 | polymers-14-05267-g003.jpg |
0.502596 | f8d285d80a5d47d096b58b460f93788c | SEM images of fracture surfaces on TiO2-filled NBR composites with (a) 0 phr TiO2 (or pure NBR), (b) 70 phr TiO2, and (c) 110 phr TiO2. | PMC9739959 | polymers-14-05267-g004.jpg |
0.57323 | 1abed5aefad34d119117e4cb9f42bd41 | (a) Storage modulus, and (b) tan δ as functions of temperature for pure NBR at several frequencies; (c) storage modulus, and (d) tan δ as functions of temperature for TiO2-filled NBR composites with various TiO2 loadings at 1 Hz. | PMC9739959 | polymers-14-05267-g005.jpg |
0.485519 | 433be4e8f6594af1a46dcc6b1a1c1cc3 | Dielectric constant of TiO2-filled NBR composites with various TiO2 loadings. | PMC9739959 | polymers-14-05267-g006.jpg |
0.481304 | 556abe4dfc4446febb99aa76bf958d0d | Schematic diagram illustrating physical bonding and interfacial adhesion in TiO2-filled NBR composites. | PMC9739959 | polymers-14-05267-sch001.jpg |
0.446709 | 0c4564f797684f08997b09f2e8116437 | Schematic illustration of the proposed reinforcing mechanism and strain-induced crystallization in TiO2-filled NBR composites. | PMC9739959 | polymers-14-05267-sch002.jpg |
0.4629 | 2438b6424b75495db576fd95c6e15078 | Differentiation of cADSC into three lineages. (a), Adipogenic differentiation identified by Oil Red O staining; (b), Osteogenic differentiation identified by Alizarin Red staining; (c), Chondrogenic differentiation identified by Alcian Blue. Bar = 100 μm. | PMC9740176 | ijms-23-14681-g001.jpg |
0.398464 | b50b9a0e87f445f39f50e4a1d57d97f5 | Infusion apparatus experiments. (a), Efficiency of live-cell infusion every 15 min using syringe pump (left panel) and infusion device (right panel). Each broken line represents the results of five independent experiments (n = 5); (b), Efficiency of live-cell infusion over 60 min. The infusion device increased efficiency of live-cell infusion approximately two-fold compared with the syringe pump; (c), Efficiency of dead-cell infusion over 60 min; (d), Cell viability after 60 min infusion. The cell viability using an infusion device was significantly higher than using a syringe pump; (e), Adherent cells in the apparatuses stained by Giemsa staining. cADSC adhered to various parts of the infusion apparatuses. No cell adhesion was observed in the tubes. * p < 0.01 vs. syringe pump. # p < 0.01, between groups. Bar = 200 μm. | PMC9740176 | ijms-23-14681-g002.jpg |
0.477408 | 44b512373fd744979bf4e2b8f07d7ff0 | Efficiency of cell infusion and cell viability in different suspension solutions. (a), Efficiency of live-cell infusion for NS and DEX. There were no significant differences, but efficiency of live-cell infusion tended to be higher in DEX; (b), Efficiency of dead-cell infusion for NS and DEX. Efficiency of dead-cell infusion also tended to be higher in DEX; (c), Cell viability after infusion for NS and DEX showed a slightly lower in DEX; (d), Microscope images of dead cADSC suspended in NS (left panel) or DEX (right panel). Trypan blue-stained dead cells suspended in NS were comparable in size and morphology to live cells (left panel; yellow arrowheads). Small concentrated Trypan Blue-stained dead cells (right panel; white arrows) and cells that appeared to be bursting (right panel; white arrowheads) were observed in DEX. NS: normal saline; DEX: 5% dextrose. Bar = 100 μm. | PMC9740176 | ijms-23-14681-g003.jpg |
0.592556 | 5d3d8c3e8d084570a8a05218392b4a17 | Differences in efficiency of cell infusion and cell viability with and without AS. (a), Efficiency of live-cell infusion with and without AS. There were no significant differences, but efficiency of live-cell infusion tended to be higher with AS; (b), Efficiency of dead-cell infusion with and without AS. Efficiency of dead-cell infusion also tended to be higher with AS; (c), Cell viability with and without AS. Supplementation of AS slightly decreased in viability. AS: allogenic serum. | PMC9740176 | ijms-23-14681-g004.jpg |
0.429587 | d83f84e4af5b49df863652ce9216d198 | Infusion time experiments. (a), Efficiency of live-cell infusion for 15, 30, and 60 min infusions. Efficiency of live-cell infusion was significantly higher for 15 and 30 min than for 60 min; (b), Efficiency of dead-cell infusion did not differ among the three time groups; (c), Cell viability after infusion tended to be higher at 15 and 30 min; (d), Differences in efficiency of live-cell infusion by infusion rate. Faster infusion rates tended to result in higher efficiency of live-cell infusion; (e), Efficiency of live-cell infusion after 15 min infusion with different suspension solutions. In contrast to infusion over 60 min, efficiency of live-cell infusion tended to be better in NS; (f), Efficiency of dead-cell infusion after 15 min infusion with different suspension solutions. Efficiency of dead-cell infusion was high at DEX, exceeding 100%; (g), Cell viability after 15 min infusion with different suspension solutions. * p < 0.01 vs. 60 min. # p < 0.05 vs. 0.33 mL/min. NS: normal saline; DEX: 5% dextrose. | PMC9740176 | ijms-23-14681-g005.jpg |
0.501303 | 18b9cabd36a04d939bc318c7bf8c4098 | Cell density experiments. (a), Efficiency of live-cell infusion at different cell densities. Higher cell density tended to result in lower efficiency of live-cell infusion; (b), Efficiency of dead-cell infusion at different cell densities. Higher cell density tended to result in higher efficiency of dead-cell infusion; (c), Cell viability at different cell densities. Higher cell density resulted in lower cell viability after infusion; (d), Effect of serum supplementation at high cell density. AS supplementation significantly improved efficiency of live-cell infusion at high cell density; (e), Effect of serum supplementation on efficiency of live-cell infusion at high cell densities; (f), Differences in cell viability after infusion with and without serum supplementation at high cell densities. * p < 0.05 vs. without AS. AS: allogenic serum. | PMC9740176 | ijms-23-14681-g006.jpg |
0.501614 | b732feb6c7f1431181bfa55c0a169e24 | Flow cytometry analysis of dead cells stained with 7-AAD. (a), Dot plots and histograms of all analyzed cells (top and middle rows), and dot plots of 7-AAD-positive cells gated by debris fraction (lower row). Although there was no significant difference, percentage of 7-AAD-positive cells were lower with NS than with DEX, and without than with AS (p = 0.05); (b), Suspension in DEX significantly increased 7-AAD-positive cells in the debris fraction. * p < 0.01, between groups. NS: normal saline; AS: allogenic serum; DEX: 5% dextrose. | PMC9740176 | ijms-23-14681-g007.jpg |
0.582182 | ad6b334bc36f4206876e8a15afbb7b69 | Optimized infusion procedure. (a), Efficiency of live-cell infusion under optimized conditions. The optimized infusion procedure significantly improved efficiency of live-cell infusion compared with the basal condition, which were the best results in this study; (b), Efficiency of dead-cell infusion of infusion under optimized conditions. Efficiency of dead-cell infusion was slightly higher than the basal condition; (c), Cell viability of infusion under optimized conditions. The optimized infusion procedure significantly improved cell viability after infusion compared with the basal condition. * p < 0.01 vs. control. # p < 0.01, between groups. | PMC9740176 | ijms-23-14681-g008.jpg |
0.400668 | bbb8d86631154fecb02b53b9625acd34 | Outline the infusion procedures. (a), Suspend 1 × 107 cADSC in 20 mL NS to prepare a cell suspension with a density of 5 × 105 cells/mL; (b), The prepared solution is collected in a 25 mL syringe with an 18G needle and transferred to an empty 50 mL infusion bag; (c), The cell-containing bag is connected to the infusion tube with a 21G winged needle; (d), The bag is placed in a drop-controlled automatic infusion device; (e), The prepared solution is collected directly in a 50 mL syringe with an 18G needle; (f), the cell-filled syringe is connected to an extension tube with a 21G winged needle; (g), the syringe was placed in a syringe pump; (h), The winged needle tip is placed in a conical tube and the infused cells were collected. The conical tubes are replaced every 15 min, mixed immediately by gentle inversion; (i), Overall view of an infusion using a syringe pump. The conical tube for collecting the flowing cell suspension is placed lower than the syringe pump and the extension tube is not deflected; (j), Overall view of an infusion using an infusion device. The cell suspensions in this series of photographs are stained red for photography to visualize suspension transfer. Yellow arrow: infusion procedure using an infusion device; White arrow: infusion procedure using a syringe pump. | PMC9740176 | ijms-23-14681-g009.jpg |
0.432819 | 6ea95c3cd7444dabab2656c6fca64c6a | Absorption spectrum and structural formula of TLP. | PMC9740293 | nanomaterials-12-04199-g001.jpg |
0.504886 | b81a7c7135c149bf96c0861e243720fe | Images of wheat after 8-days treatment with various solutions of TLP under irradiation: TiO2 and SSI (A); TiO2 and UV (B); ZnO and SSI (C); ZnO and UV (D). | PMC9740293 | nanomaterials-12-04199-g002.jpg |
0.398467 | bbde295deae34d8ba7b5907f626c9783 | Classification of the samples based on the percentage of tolperisone (TLP) after irradiation. | PMC9740293 | nanomaterials-12-04199-g003.jpg |
0.393391 | 09848afb9d9a4275952b3b9a50ef6dd2 | Classification of the samples based on germination. | PMC9740293 | nanomaterials-12-04199-g004.jpg |
0.460296 | 75389ecf24ca4a74bedc9cb626ffff5b | Kinetics of photocatalytic degradation of TLP (0.05 mM) in the presence of TiO2 under SSI (A) and UV irradiation (B). | PMC9740293 | nanomaterials-12-04199-g005.jpg |
0.400825 | b188d10a16f14b0fa7d1fa767e242a05 | Kinetics of photocatalytic degradation of TLP (0.05 mM) in the presence of ZnO under SSI (A) and UV irradiation (B). | PMC9740293 | nanomaterials-12-04199-g006.jpg |
0.433939 | 131da9d299de43e09ae9146344eb577b | LC–MS spectrum of TLP standard (A); sample in the presence of catalyst (1.0 mg/mL) after 60 min of irradiation under UV irradiation (B). | PMC9740293 | nanomaterials-12-04199-g007.jpg |
0.529275 | 0f22460af6e24ac2b6fc2c6bb055e709 | Optimal degradation of TLP after irradiation (A); optimal parameters for germination of wheat seeds (B). | PMC9740293 | nanomaterials-12-04199-g008.jpg |
0.480819 | 69bfcb3270ba419b9a0b4c85c92b598f | Hybrid-manufacturing process design and scheme applied to produce turbine blade workpiece out of AlSi5 alloy by cooperatively combined robotic WAAM and milling. | PMC9740583 | materials-15-08631-g001.jpg |
0.4498 | aa04c690686f4214ac37dd4713d6a466 | Experimental robotic setups: (a) robotic welding cell and (b) robotic cell with milling unit attachment. | PMC9740583 | materials-15-08631-g002.jpg |
0.391539 | a33b74787c754c579586c30f6618f4c0 | (a) Robotic head with electronic milling spindle drive, and (b) spindle cooling system with the frequency converter. | PMC9740583 | materials-15-08631-g003.jpg |
0.442834 | 6ba8d121fd3548fd9b8890591a1214d9 | WAB312061 Carbide cutting tool with 6 mm diameter having two cutting edges. | PMC9740583 | materials-15-08631-g004.jpg |
0.456322 | 0b314f3da9ea46f6ab0f4f4384323e9a | Turbine blade prototype model (dimensions in mm). | PMC9740583 | materials-15-08631-g005.jpg |
0.444348 | 2560d6a193d44ca6a4de6fa79cdda258 | Division of workpiece to eight 20 mm segments, up to length of 153 mm. | PMC9740583 | materials-15-08631-g006.jpg |
0.45592 | efff833349fe485ebed146af02bdf813 | Welding torch movement feed during deposition on flat walls (parallel to base surface). | PMC9740583 | materials-15-08631-g007.jpg |
0.415726 | 7badde698605431fa3c65dd5add7a692 | Melting of deposited wall at excessively high inter-layer temperature of >120 °C. | PMC9740583 | materials-15-08631-g008.jpg |
0.448562 | 0bd3e723df6b416e9060ac7150360e81 | Different WAAM deposition test conditions: A1–A4 at higher welding speed pf 10 mm/s, B1–B5 at intermediate welding speed of 8 mm/s, and C1–C4 at slower welding speed of 6 mm/s. | PMC9740583 | materials-15-08631-g009.jpg |
0.438012 | a2fe0a82af984db1b4ba1d8d2b0a5149 | Strategies for surfacing of flat wall at an angled deposition by (a) shifting the burner and (b) titling the burner. | PMC9740583 | materials-15-08631-g010.jpg |
0.400043 | 5605a829d3c44337a9a63849723cfa83 | Surface deposition of flat walls at an angle of (a) 75°, (b) 60°, and (c) 45°, according to burner offset/shift. | PMC9740583 | materials-15-08631-g011.jpg |
0.461873 | 77e9edfbb4014e80a9ad6967195b274d | Direct energy surface deposition of flat walls at an angle of (a) 75°, (b) 60°, and (c) 45°, with titled welding torch. | PMC9740583 | materials-15-08631-g012.jpg |
0.472429 | 00bc7535c45244c9bc66396e21eeec9f | (a) Placement of workpiece in work area of welding robot and (b) layout of workpiece coordinate system for welding deposition. | PMC9740583 | materials-15-08631-g013.jpg |
0.466629 | 4d059b71974b4d2898edcffdae51d340 | Orientation of welding burner and deposition path (green lines) in the direction of structure construction. | PMC9740583 | materials-15-08631-g014.jpg |
0.443662 | 781cd5927e814fcaadef2fd92364232a | Orientation of tool during machining of the sixth segment, from the (a) left, (b) rear, (c) right, and (d) front. | PMC9740583 | materials-15-08631-g015.jpg |
0.428914 | 48e27c84a9b04202bec9d7ca54ea0421 | Finishing operations performed on the (a) side surface from the rotational one-way bottom-up strategy and (b) the top surface in rectangular orientation. | PMC9740583 | materials-15-08631-g016.jpg |
0.436457 | bd2b0842e94d46b9b80e81fd25c34e59 | Stages of prototype fabrication by weldment deposition and subsequent milling: (a) first stage of deposition from 0–20 mm; (b) milling to 20 mm height; (c) second stage deposition up to 40 mm followed by (d) machining at 40 mm; (e) third stage deposition 40–60 mm and (f) milling third deposited segment to 60 mm; (g) intermediate weldment structure in fourth stage at 60–80 mm and (h) follow-up machining to 80 mm. | PMC9740583 | materials-15-08631-g017.jpg |
0.415651 | 4af60fca09e341aa86ff8237ed32e5b5 | Intermediate to final stage of turbine blade fabrication up to 153 mm in height after (a) weld deposition at 80–100 mm and (b) follow-up milling to 100 mm; (c) the sixth stage from 100–120 mm by alloy deposition; (d) machined to a height of 120 mm; (e) weldment structure from 120–140 mm and (f) subsequent milling of seventh stage to 140 mm; (g) lastly, the final deposit in eight stages from 140 mm to 153 mm, which was milled to specifications in (h). | PMC9740583 | materials-15-08631-g018.jpg |
0.439769 | 90126f3d547947f88d2d37c9e3414192 | After the final phase 2 machining of the optimally built workpiece: (a) side view and (b) top view of 8 depositions and 11 layers in total from the (c) cross-section slice image. | PMC9740583 | materials-15-08631-g019.jpg |
0.41286 | cc552f5698444ab7a600205415d50939 | CAD model developed from 3D-scanned prototype showing: (a) front view, (b) rear view, (c) top view, (d) side view 1, (e) side view 2, (f) frontal side view, and (g) cross-side view. | PMC9740583 | materials-15-08631-g020.jpg |
0.410057 | bade1b8b45954ba8a56191546f972e91 | Measured deviation of prototype from CAD model shown with average value, standard deviation, and the minima/maxima values. | PMC9740583 | materials-15-08631-g021.jpg |
0.424165 | f706f68b0fa24900a0f0a18df610a1a1 | Measurement of the weldment surface at (a) 100 mm height in fifth stage of deposition, (b) higher-magnification optical image of corrugation between welding layers between 80–100 mm, and (c) surface topographical profile. | PMC9740583 | materials-15-08631-g022.jpg |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.